51 – 60 of 155
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
(
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications.
(
- Contribution to journal › Scientific review
-
Mark
Mechanisms of Dopamine D1 Receptor-Mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5.
2014) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 34(13). p.4728-4740(
- Contribution to journal › Article
-
Mark
Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.
(
- Contribution to journal › Article
-
Mark
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
2014) p.373-386(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
2014) In Proceedings of the National Academy of Sciences of the United States of America 111(12). p.4578-4583(
- Contribution to journal › Article
-
Mark
Preclinical models of levodopa-induced dyskinesia
2014) p.335-353(
- Chapter in Book/Report/Conference proceeding › Book chapter